Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-006462
Filing Date
2023-06-15
Accepted
2023-06-15 12:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29709
2 filename2.txt TEXT-EXTRACT 4788
  Complete submission text file 0000000000-23-006462.txt   46550
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filed for) CIK: 0001739426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations